Replimune Group, Inc. (REPL)
6.98
+0.09
(+1.31%)
USD |
NASDAQ |
Mar 20, 16:00
6.80
-0.18
(-2.58%)
After-Hours: 06:06
Replimune Group EPS Diluted (Quarterly) : -0.7694 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| REGENXBIO, Inc. | -1.298 |
| ANI Pharmaceuticals, Inc. | 1.172 |
| Phathom Pharmaceuticals, Inc. | -0.2865 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Sarepta Therapeutics, Inc. | -3.934 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -70.93M |
| Total Expenses (Quarterly) | 70.93M |
| Enterprise Value | 383.57M |
| Earnings Yield | -51.33% |
| Normalized Earnings Yield | -51.33 |